Newer cyclo-oxygenase-2 selective inhibitors, other non-steroidal anti-inflammatory drugs and the risk of acute pancreatitis

Alimentary Pharmacology and Therapeutics

Volumn 24, Issue 1, 2006, Pages 111-116

  Sorensen H T ^a   Jacobsen, J ^a   Norgaard M ^a   Pedersen, L ^a   Johnsen, S P ^a   Baron, J A ^b  

^a AARHUS UNIVERSITY HOSPITAL   (Denmark)

^b DARTMOUTH MEDICAL SCHOOL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AZATHIOPRINE; CELECOXIB; CYCLOOXYGENASE 2 INHIBITOR; DICLOFENAC; ETODOLAC; GLUCOCORTICOID; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR; IBUPROFEN; INDOMETACIN; KETOPROFEN; NAPROXEN; NONSTEROID ANTIINFLAMMATORY AGENT; ROFECOXIB;

ACUTE PANCREATITIS; ADULT; AGED; ARTICLE; CONFIDENCE INTERVAL; CONTROLLED STUDY; DENMARK; FEMALE; HOSPITAL DISCHARGE; HUMAN; INFECTION RISK; LOGISTIC REGRESSION ANALYSIS; MAJOR CLINICAL STUDY; MALE; POPULATION BASED CASE CONTROL STUDY; PRIORITY JOURNAL; RISK ASSESSMENT; RISK FACTOR;

ACUTE DISEASE; ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; ANTI-INFLAMMATORY AGENTS, NON-STEROIDAL; CASE-CONTROL STUDIES; CYCLOOXYGENASE INHIBITORS; FEMALE; HUMANS; MALE; MIDDLE AGED; PANCREATITIS; RISK FACTORS;

EID: 33745168599     PISSN: 02692813     EISSN: 13652036     Source Type: Journal    
DOI: 10.1111/j.1365-2036.2006.02959.x     Document Type: Article

References (31)

1. Hernandez-Diaz S Garcia-Rodriguez LA. Epidemiologic assessment of the safety of conventional nonsteroidal anti-inflammatory drugs. Am J Med 2001 110 ( Suppl. 3A 20S 7S.
2. Mellemkjær L Blot WJ Sørensen HT, et al. Upper gastrointestinal bleedings among users of NSAIDs: a population-based cohort study in Denmark. Br J Clin Pharmacol 2002 53 : 173 81.
3. Zygmunt D Williams H Bienz S. Acute pancreatitis associated with long-term sulindac therapy. West J Med 1986 144 : 461 2.
4. Sugerman H. Sulindac-induced acute pancreatitis mimicking gallstone pancreatitis. Am Surg 1989 55 : 536 8.
5. Goldstein J Laskin D Ginsberg G. Sulindac associated with pancreatitis. Ann Intern Med 1980 93 : 115.
6. Lilly E. Pancreatitis after administration of sulindac. JAMA 1981 246 : 2680.
7. Memon A. Pancreatitis and sulindac. Ann Intern Med 1982 96 : 139.
8. Siefkin A. Sulindac and pancreatitis. Ann Intern Med 1980 93 : 932 3.
9. Klein S Khan M. Hepatitis, toxic epidermal necrolysis and pancreatitis in association with sulindac therapy. J Rheumatol 1983 10 : 512 3.
10. Guerra M. Toxicity of indomethacin: report of a case of acute pancreatitis. JAMA 1967 200 : 552 3.
11. Cobb T Piero J. Acute pancreatitis associated with ketoprofen. South Med J 1992 85 : 430 1.
12. Khan I Edward N. Pancreatitis associated with diclofenac. Postgrad Med J 1993 69 : 486 7.
13. Du Ville L Debeuckelaere S Reynaert H Devis G. Pancreatitis associated with naproxen. Gastroenterology 1993 88 : 464.
14. Sussmann S. Severe salicylism and acute pancreatitis. Calif Med 1963 99 : 29 32.
15. Wilmink T Frick TW. Drug-induced pancreatitis. Drug Saf 1996 14 : 406 23.
16. McArthur KE. Review article: Drug-induced pancreatitis. Aliment Pharmacol Ther 1996 10 : 23 38.
17. Blomgren KB Sundstrom A Steineck G Genell S Sjostedt S Wiholm BE. A Swedish case-control network for studies of drug-induced morbidity-acute pancreatitis. Eur J Clin Pharmacol 2002 58 : 275 83.
18. Laine L. The gastrointestinal effects of nonselective NSAIDs and COX-2-selective inhibitors. Semin Arthritis Rheum 2002 32 : 25 32.
19. Johnsen SP Larsson H Tarone RE, et al. Risk of hospitalization for myocardial infarction among users of rofecoxib, celecoxib, and other NSAIDs. A population-based case-control study. Arch Intern Med 2005 165 : 978 83.
20. Psaty BM Furberg CD. COX-2 inhibitors - lessons in drug safety. N Engl J Med 2005 352 : 33 5.
21. Baciewicz AM Sokos DR King TJ. Acute pancreatitis associated with celecoxib. Ann Intern Med 2000 132 : 680.
22. Nind G Selby W. Acute pancreatitis: a rare complication of celecoxib. Intern Med J 2002 32 : 624 5.
23. Floyd A Pedersen L Nielsen GL Thorlacius-Ussing O Sørensen HT. Risk of acute pancreatitis in users of azathioprine: a population-based case-control study. Am J Gastroenterol 2003 98 : 1305 8.
24. Floyd A Pedersen L Nielsen GL Thorlacius-Ussing O Sørensen HT. Secular trends in incidence and 30-day case fatality of acute pancreatitis in North Jutland County, Denmark: a register-based study from 1981-2000. Scand J Gastroenterol 2002 37 : 1461 5.
25. Nørgaard M Ratanajamit C Jacobsen J Skriver MV Pedersen L Sørensen HT. Metronidazole and risk of acute pancreatitis: a population-based case-control study. Aliment Pharmacol Ther 2005 21 : 415 20.
26. Cryer B Feldman M. Cyclooxygenase-1 and cyclooxygenase-2 selectivity of widely used nonsteroidal anti-inflammatory drugs. Am J Med 1998 104 : 413 21.
27. Szklo M Nieto FJ. Epidemiology Beyond the Basics, 1st edn. Gaithersburg, Maryland, USA : Aspen Publishers, 2000.
28. Henry D Lim LL Garcia Rodriguez LA, et al. Variability in risk of gastrointestinal complications with individual non-steroidal anti-inflammatory drugs: results of a collaborative meta-analysis. BMJ 1996 312 : 1563 6.
29. Hawkey CJ. COX-2 inhibitors. Lancet 1999 353 : 307 14.
30. Schneeweiss S Glynn RJ Tsai EH Avorn J Solomon DH. Adjusting for unmeasured confounders in pharmacoepidemiologic claims data using external information: the example of COX2 inhibitors and myocardial infarction. Epidemiology 2005 16 : 17 24.
31. Nørgård B Pedersen L Johnsen SP, et al. COX-2-selective inhibitors and the risk of upper gastrointestinal bleeding in high-risk patients with previous gastrointestinal diseases: a population-based case-control study. Aliment Pharmacol Ther 2004 19 : 817 25.